# Jiangsu Neulive Medtech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangsu-neulive-medtech-co

- Industry: Medical Devices & Equipment
- Headquarters: Nantong, China
- Website: www.neulive.cn
- Latest round: Series A (Dec 10, 2021)
- Investors on record: 2

## About

Based in Nantong, China and founded in 2019, Jiangsu Neulive Medtech Co.,Ltd operates as a medical company that focuses on the development and production of interventional medical devices in the neurological field. It has research and development centers in Shanghai and California. The company currently has 3 products that have been certified. In January 2026, Jiangsu Neulive Medtech Co.,Ltd closed a venture funding from Optics Valley Industrial Investment Fund Management and Jifeng Ventures.

The company is mainly engaged in the research, development, production, and sales of neuroscience medical devices. It self-developed stroke and hemorrhage products such as dense mesh stents, auxiliary stents, intratumoral embolization devices, aspiration devices, catheters, guide wires, and other stroke ischemia and access products. Products can be used to treat hemorrhage and ischemic stroke, pain, epilepsy, Parkinson's disease, obsessive-compulsive disorder, and other diseases.

The company generates revenue by providing interventional medical devices in the neurological field.

## Funding rounds

- Series A, Dec 10, 2021 — CD Capital, Jifeng Ventures

## Investors

- CD Capital — Series A
- Jifeng Ventures (https://capitalatlas.ai/funds/jifeng-ventures) — Series A